SGEN

Seattle Genetics, Inc. News Headlines

$35.95
*  
0.35
0.98%
Get SGEN Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading SGEN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
First Week of June 2015 Options Trading For Seattle Genetics (SGEN)
10/23/2014 12:21:51 PM - BNK Invest


Stock Weakness in Seattle Genetics, Gilead Sciences Belies Fundamental Strengths
10/15/2014 9:35:00 AM - TheStreet


Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma
10/3/2014 9:41:00 AM - TheStreet


Seattle Genetics-Takeda Reveal Impressive Adcetris Data - Analyst Blog
10/1/2014 3:30:00 PM - Zacks.com


Will This Analyst Downgrade Hurt Seattle Genetics (SGEN) Stock Today?
9/30/2014 9:44:00 AM - TheStreet


Seattle Genetics Seeks Expanded Use of Lymphoma Drug Following Study Win
9/29/2014 9:31:00 AM - TheStreet


Sector Update: Health-Care Shares Sink in Pre-Market Trade
9/29/2014 8:39:13 AM - MT Newswires


Sector Update: Health Care
9/29/2014 8:38:27 AM - MT Newswires


Seattle Genetics, Takeda Report Positive Data From Phase 3 Trial Of ADCETRIS
9/29/2014 6:53:00 AM - RTT News


Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog
9/25/2014 6:27:00 PM - Zacks.com


Interesting SGEN Put And Call Options For November 22nd
9/24/2014 12:25:58 PM - BNK Invest


Merck KGaA Teams Up with Sutro for ADCs Targeting Cancer - Analyst Blog
9/18/2014 7:00:00 PM - Zacks.com


Seattle Genetics, Genmab In New Antibody-Drug Conjugate Collaboration
9/10/2014 12:14:00 PM - RTT News


Seattle Genetics (SGEN) Shares Cross Below 200 DMA
9/5/2014 11:50:13 AM - BNK Invest


Kite Pharma Drug Fares Well in Non-Hodgkin's Lymphoma Study - Analyst Blog
8/26/2014 6:44:00 PM - Zacks.com


Risk And Reward Seem Pretty Balanced At Seattle Genetics
8/19/2014 5:21:00 PM - Seeking Alpha


First Week of SGEN October 18th Options Trading
8/19/2014 1:50:18 PM - BNK Invest


Can the Rally in Seattle Genetics (SGEN) Shares Continue? - Tale of the Tape
8/18/2014 9:36:18 AM - Zacks.com


Seattle Genetics (SGEN) Shares Cross Above 200 DMA
8/12/2014 11:38:41 AM - BNK Invest


Seattle Genetics Begins Phase 1 Trial Of SGN-CD70A For NHL And RCC - Quick Facts
8/12/2014 9:10:00 AM - RTT News


AbbVie's ABT-414 Receives Orphan Drug Status in U.S. and EU - Analyst Blog
8/5/2014 5:50:00 PM - Zacks.com


Seattle Genetics Up on Narrower-than-Expected Q2 Loss - Analyst Blog
8/4/2014 4:20:00 PM - Zacks.com


ALXA Working Its Way, CERS Awaits FDA Decision, XNCR, SGEN Look Ahead To Results
8/1/2014 12:32:00 AM - RTT News


Seattle Genetics Q2 Loss Widens
7/31/2014 5:34:00 PM - RTT News


Seattle Genetics Q2 14 Earnings Conference Call At 4:30 PM ET
7/31/2014 3:06:00 PM - RTT News